RPL32P30

Across TCGA pan-cancer cohorts, RPL32P30 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPL32P30’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RPL32P30 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL32P30 is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

THCA, KIRP, and BRCA are the cancer types where RPL32P30 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P30 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	III,IV	−0.115	.002	7	view →
KIRP	All	All	−0.100	.015	4	view →
BRCA	Female	All	−0.066	.007	4	view →
KICH	All	All	−0.131	.002	3	view →
HNSC	Male	All	−0.115	.012	2	view →
LUSC	Male	All	−0.052	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPL32P30–THCA

Open the THCA breakdown →